Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adicon HoldingsFRA:K0U -10.95%75 Days Payable is 144.29 as of Dec. 2025, which is 16% above its 10-year median of 124.44. GuruFocus rates FRA:K0U with a GF Score™ of 75/100 and a GF Value™ of €0.77. The stock has 6 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Adicon Holdings ranks better than 74.21% on this metric.
The historical rank and industry rank for Adicon Holdings's Days Payable or its related term are showing as below:
FRA:K0U'
s Days Payable Range Over the Past 10 Years
Min: 83.14 Med: 124.44 Max: 178.89
Current: 150.06
During the past 6 years, Adicon Holdings's highest Days Payable was 178.89. The lowest was 83.14. And the median was 124.44.
FRA:K0U's Days Payable is ranked better than 74.21% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 64.64
vs FRA:K0U: 150.06
Adicon Holdings's Days Payable
increased
from Dec. 2024 (141.45) to Dec. 2025 (144.29).
It may suggest that Adicon Holdingsdelayed paying its suppliers.
Adicon Holdings Days Payable Related Terms
Adicon Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for Adicon Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:K0U vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Adicon Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adicon Holdings Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Adicon Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Adicon Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Adicon Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adicon Holdings (FRA:K0U) has a Days Payable of 144.29 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Adicon Holdings and its competitors. This is 16% above median its historical median of 124.44. Over the past decade, Adicon Holdings' Days Payable has ranged from 83.14 to 178.89. According to the industry distribution chart, Adicon Holdings ranks #49 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 25.8%.
Is Adicon Holdings' Days Payable too high?
Adicon Holdings' current Days Payable of 144.29 is 16% above median its 10-year median of 124.44. Over the past 10 years, this metric has ranged from a low of 83.14 to a high of 178.89. The Medical Diagnostics & Research industry median Days Payable is 64.64. Adicon Holdings' value of 144.29 is 123.2% above this industry median. Based on the distribution chart, Adicon Holdings ranks #49 out of 190 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Adicon Holdings has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Adicon Holdings' Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Adicon Holdings ranks #49 out of 190 companies for Days Payable. This puts Adicon Holdings in the upper half of its industry. The industry median Days Payable is 64.64. Adicon Holdings' value of 144.29 is 123.2% above this benchmark. Historically, Adicon Holdings' own Days Payable has ranged from 83.14 to 178.89 over the past decade. While the company's 10-year median is 124.44 vs. the industry median of 64.64, Adicon Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 64.64, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adicon Holdings's current Days Payable of 144.29 is 123.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Adicon Holdings and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 64.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adicon Holdings's current Days Payable is 144.29, which is 16% above median its own 10-year median of 124.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adicon Holdings stock overvalued right now?
Adicon Holdings (FRA:K0U) has a current Days Payable of 144.29. The stock's GF Value™ is €0.77, compared to a current price of €0.36 — trading 53.5% below its estimated fair value. The current Days Payable is 144.29, which is 16% above median its 10-year median of 124.44 and 123.2% above the Medical Diagnostics & Research industry median of 64.64. Adicon Holdings' overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Adicon Holdings (FRA:K0U), the current Days Payable is 144.29 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adicon Holdings (FRA:K0U) Overvalued in 2026?
Based on GuruFocus' analysis, Adicon Holdings stock appears to be undervalued.
The current stock price of €0.36 is trading 53.5% below its estimated GF Value™ of €0.77.
Key valuation signals for FRA:K0U:
Days Payable: 144.29 (16% above median its 10-year median of 124.44)
GF Value™: €0.77 vs. price of €0.36 (53.5% below fair value)
Industry Position: 123.2% above the Medical Diagnostics & Research median (#49 of 190)
No single metric tells the full story. See the FRA:K0U stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adicon Holdings Ltd is a ICL service provider in China. It offers comprehensive testing services to hospitals and health check centers through an integrated network of self-operated laboratories across China. Its testing services platform includes clinical laboratories, pathology laboratories, reproductive genetics laboratories, gene laboratories, and mass spectrometry laboratories, consisting of over 4,000 medical diagnostic tests, the introduction of over 300 new high-end diagnostic tests.
75GF Score
Get the complete analysis for FRA:K0U
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:K0U has been successfully added to your 
